DRUG

Bright Minds Biosciences Inc

• TipRanks·10/02 21:27

  Bright Minds Biosciences Shareholders Back Board and Auditor at March 2026 AGM

• TipRanks·10/01 11:36

  Bright Minds Biosciences (DRUG) Receives a Buy from Piper Sandler

• TipRanks·09/30 22:04

  Bright Minds Deepens Prader-Willi Focus as BMB-101 Advances in Phase 2 Trial

• TipRanks·09/28 10:30

  Bright Minds initiated with an Outperform at LifeSci Capital

• TipRanks·09/28 10:15

  Analyst Reiterates Buy on Bright Minds Biosciences, Citing Differentiated 5-HT2C Epilepsy Asset and Multibillion-Dollar Upside vs. Current Valuation

• TipRanks·09/22 09:45

  Bright Minds Biosciences (DRUG) Receives a Rating Update from a Top Analyst

• TipRanks·09/17 12:45

  Piper Sandler Sticks to Its Buy Rating for Bright Minds Biosciences (DRUG)

• Seeking Alpha·09/09 00:25

  FDA names acting heads of drug and vaccine units to permanent roles

• NASDAQ·08/27 16:00

  What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?

• TipRanks·08/20 15:30

  Psychedelic: Enveric, Helus, Bright Minds report earnings results

• TipRanks·08/19 16:35

  Bright Minds Biosciences: Buy Rating Reaffirmed with Unchanged $145 Target on BMB-101 Phase 3 Pathway and Pipeline Upside

• Benzinga·08/19 15:12

  HC Wainwright & Co. Reiterates Buy on Bright Minds Biosciences, Maintains $145 Price Target

• Benzinga·08/17 16:24

  BTIG Reiterates Buy on Bright Minds Biosciences, Maintains $147 Price Target

• Seeking Alpha·08/10 12:23

  Bright Minds: BMB-101 Takes Center Stage Ahead Of Phase 3 Pivotal Trials

• Seeking Alpha·07/19 13:05

  Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus